SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 27 filers reported holding SCPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,133 | -13.3% | 3,019 | 0.0% | 0.00% | – |
| Q1 2024 | $15,156 | -19.9% | 3,019 | 0.0% | 0.00% | – |
| Q4 2023 | $18,929 | -11.9% | 3,019 | 0.0% | 0.00% | – |
| Q3 2023 | $21,495 | -39.5% | 3,019 | -13.4% | 0.00% | – |
| Q2 2023 | $35,523 | +492.0% | 3,486 | +321.5% | 0.00% | – |
| Q1 2021 | $6,000 | +50.0% | 827 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | -33.3% | 827 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 827 | -5.9% | 0.00% | – |
| Q2 2020 | $6,000 | +50.0% | 879 | -30.5% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 1,265 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -20.0% | 1,265 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -28.6% | 1,265 | 0.0% | 0.00% | – |
| Q3 2018 | $7,000 | 0.0% | 1,265 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | -56.2% | 1,265 | 0.0% | 0.00% | – |
| Q1 2018 | $16,000 | – | 1,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,253,440 | $24,075,000 | 7.45% |
| RA Capital Management | 3,518,998 | $26,041,000 | 0.82% |
| Alambic Investment Management, L.P. | 41,523 | $307,000 | 0.74% |
| Worth Venture Partners, LLC | 143,646 | $1,063,000 | 0.65% |
| Ikarian Capital, LLC | 1,073,647 | $7,945,000 | 0.60% |
| Orbimed Advisors | 3,409,865 | $25,233,000 | 0.42% |
| Eversept Partners, LP | 132,419 | $979,901 | 0.24% |
| Matisse Capital | 27,685 | $205,000 | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 115,388 | $854,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,200 | $475,000 | 0.01% |